CTLT

Catalent, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
$63.48
+0.00 (+0.00%)
Mkt Cap: 11.52B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield-0.6%
Dividend YieldN/A
Market Cap11.52B
Volume13.67M
Recent News
Cartherics and Catalent Expand Commercial License Agreement
businesswire.com · 2026-04-09
Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases
businesswire.com · 2026-03-11

Unlock the Full Deep Scan

9 AI agents analyze CTLT across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →